The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception最新文献

{"title":"Contraception for transgender and gender diverse people.","authors":"Alessandra Lami, Manuela Farris, Maria Cristina Meriggiola","doi":"10.1080/13625187.2026.2745922","DOIUrl":"https://doi.org/10.1080/13625187.2026.2745922","url":null,"abstract":"<p><strong>Introduction: </strong>Contraceptive counselling and contraception prescription in transgender and gender-diverse (TGD) individuals remain an underrecognized aspect of TGD care, and dedicated recommendations are still limited.</p><p><strong>Methods: </strong>This Expert Opinion aims to provide up-to-date practical guidance for clinicians on this topic, based on a comprehensive review of the available literature, current international recommendations, and the authors' clinical experience.</p><p><strong>Results: </strong>It reviews the available contraceptive options, including short-acting and long-acting reversible contraceptives, barrier methods, and permanent contraception, discussing their advantages, limitations, and clinical applicability in the context of gender-affirming hormone therapy (GAHT). Particular attention is paid to contraceptive counselling, menstrual suppression, management of unscheduled bleeding, and practical aspects that may influence contraceptive choice and adherence in TGD population.</p><p><strong>Conclusion: </strong>This Expert Opinion provides practical recommendations to support individualised contraceptive counselling and evidence-informed contraceptive prescribing, with the aim of improving reproductive healthcare and promoting informed shared decision-making for TGD individuals.</p>","PeriodicalId":520795,"journal":{"name":"The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception","volume":" ","pages":"1-14"},"PeriodicalIF":2.0,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149187693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Knowledge, perceptions and counselling practices regarding vasectomy among Portuguese physicians: a cross-sectional study.","authors":"Marta Campos, Mariana Leal, Margarida Neves da Silva, Marta Xavier, Ana Paula Santos, Luís Ferraz, Inês Nunes","doi":"10.1080/13625187.2026.2741054","DOIUrl":"https://doi.org/10.1080/13625187.2026.2741054","url":null,"abstract":"<p><strong>Purpose: </strong>To assess knowledge, perceptions and counselling practices regarding vasectomy among Portuguese physicians from Obstetrics and Gynaecology (OB/GYN) and General and Family Medicine (GFM) specialties.</p><p><strong>Materials and methods: </strong>A national cross-sectional observational study was conducted using online structured questionnaires. Information on sociodemographic and professional characteristics, physicians' knowledge, perceptions, and counselling practices regarding vasectomy was collected. Statistical analyses included Chi-square, Mann-Whitney U, Fisher, t-student, and Kruskal-Wallis tests, with significance set at <i>p</i> < 0.05.</p><p><strong>Results: </strong>A total of 290 physicians were included - 136 OB/GYN (46.9%) and 154 GFM (53.1%). Self-perceived knowledge was mostly rated as acceptable (62.4%) or good (23.4%), without statistically significant differences between groups. A knowledge score was created based on 16 knowledge questions. OB/GYN physicians presented higher knowledge scores than GFM physicians (13.40 ± 1.96 vs. 12.65 ± 2.41; <i>p</i> = 0.008).</p><p><strong>Conclusions: </strong>Portuguese physicians demonstrated a high proportion of correct responses and positive attitudes towards vasectomy. Nevertheless, OB/GYN presented higher knowledge scores. Persistent gaps in medical knowledge and structural barriers within female-centred contraceptive counselling may still limit the routine inclusion of vasectomy.</p>","PeriodicalId":520795,"journal":{"name":"The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception","volume":" ","pages":"1-11"},"PeriodicalIF":2.0,"publicationDate":"2026-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149130265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Statement of retraction: family planning perspectives and practices of married adolescent girls in rural Upper Egypt.","authors":"","doi":"10.1080/13625187.2026.2719156","DOIUrl":"10.1080/13625187.2026.2719156","url":null,"abstract":"","PeriodicalId":520795,"journal":{"name":"The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception","volume":" ","pages":"418"},"PeriodicalIF":2.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148808870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Female genital mutilation: perception of Portuguese gynecologists and obstetricians - a national survey.","authors":"Dinis Mateus, Catarina Toscano, Ana Catarina Neves, Maria Rodrigues, Ângela Ferreira, Amália Pacheco, Teresa Bombas","doi":"10.1080/13625187.2026.2693185","DOIUrl":"10.1080/13625187.2026.2693185","url":null,"abstract":"<p><strong>Introduction: </strong>Female genital mutilation (FGM) comprises non-medical procedures involving partial or total removal of the external female genitalia and remains a public health concern in Europe, including Portugal, due to migration from high-prevalence countries.</p><p><strong>Objective: </strong>This study aimed to assess the perceptions and experiences of Portuguese gynaecologists and obstetricians regarding FGM.</p><p><strong>Methods: </strong>A nationwide cross-sectional survey was conducted using a 13-item anonymous electronic questionnaire distributed via email and WhatsApp^® to Portuguese gynaecologists and obstetricians residents and specialists through professional societies. Data were analysed using descriptive statistics, chi-square tests, and logistic regression (<i>p</i> < 0.05).</p><p><strong>Results: </strong>A total of 172 Portuguese gynaecologists and obstetricians completed the survey. Overall, 43.0% reported previous clinical contact with women affected by FGM. Previous contact with FGM was significantly associated with knowledge of FGM classification (OR = 3.66, 95% CI 1.89-7.11; <i>p</i> < 0.001), having sought information or training on FGM (OR = 11.58, 95% CI 5.64-23.80; <i>p</i> < 0.001), awareness of countries where FGM is practiced (OR = 6.07, 95% CI 1.73-21.29; <i>p</i> = 0.005), and reporting cases to authorities (OR = 18.77, 95% CI 2.38-148.00; <i>p</i> = 0.005).</p><p><strong>Conclusions: </strong>Despite clinical exposure, important knowledge and preparedness gaps persist, highlighting the need for targeted training and national guidance to improve FGM-related care in Portugal.</p>","PeriodicalId":520795,"journal":{"name":"The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception","volume":" ","pages":"408-417"},"PeriodicalIF":2.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148407779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Contraceptive effectiveness of a digital contraceptive with a wearable device vs an oral thermometer.","authors":"Agathe van Lamsweerde, Anita Nelson, Kristina Gemzell-Danielsson, Elina Berglund Scherwitzl, Raoul Scherwitzl, Kerry Krauss, Eleonora Benhar","doi":"10.1080/13625187.2026.2671267","DOIUrl":"10.1080/13625187.2026.2671267","url":null,"abstract":"<p><strong>Purpose: </strong>To inform contraceptive decisions, we aimed to compare the pregnancy and continuation rates of a digital contraceptive, when paired with temperature data from wearable devices versus from oral thermometers.</p><p><strong>Materials and methods: </strong>We employed prospectively collected data from women who registered to Natural Cycles for contraception between the 1st of August 2022 and the 1st of September 2024. Using Kaplan-Meier curves, we calculated 13-cycle pregnancy rates in typical and perfect use as well as one-year continuation rates. We estimated the association of known demographic characteristics with pregnancy rates using a multivariate Cox proportional hazards model.</p><p><strong>Results: </strong>Among the 195 027 presumed fertile women whom we analysed, the unadjusted 13-cycle pregnancy rate for wearable device users was significantly lower than for oral thermometer users both in typical use (4.7% vs 7.3%; <i>p</i> < 0.001) and in perfect use (2.0% vs 2.9%; <i>p</i> < 0.001). However, when adjusting for demographics, measuring with a wearable device rather than a thermometer was not independently associated with pregnancy. We observed one-year continuation rates of 75.8% for wearable device users and 56.4% for thermometer users.</p><p><strong>Conclusions: </strong>Findings from this study suggest that combining a contraceptive app with a wearable device rather than an oral thermometer does not affect pregnancy rates when adjusting for socio-demographic variables. However, the substantial increase in continuation implies greater user convenience.</p>","PeriodicalId":520795,"journal":{"name":"The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception","volume":" ","pages":"350-361"},"PeriodicalIF":2.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147978569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Expression of concern: Evaluation of knowledge and practice of hymenoplasty among Egyptian gynaecologists: a cross-sectional study.","authors":"","doi":"10.1080/13625187.2026.2705701","DOIUrl":"10.1080/13625187.2026.2705701","url":null,"abstract":"","PeriodicalId":520795,"journal":{"name":"The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception","volume":" ","pages":"419"},"PeriodicalIF":2.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148564430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Desogestrel, etonogestrel and meningioma risk: how frequent does an adverse effect have to be worth mentioning?","authors":"Giovanni Grandi, Carlo Bastianelli, Manuela Farris","doi":"10.1080/13625187.2026.2718925","DOIUrl":"10.1080/13625187.2026.2718925","url":null,"abstract":"","PeriodicalId":520795,"journal":{"name":"The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception","volume":" ","pages":"337-339"},"PeriodicalIF":2.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148805531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Dissociation of gonadal and adrenal androgens one year after etonogestrel implant insertion.","authors":"Meryem Kececi Oguzhanoglu, Senem Karacabey Cakmak, Kubra Sevim Pehlivan, Ezgi Gungor, Kursat Oguzhanoglu, Ali Cetin","doi":"10.1080/13625187.2026.2692388","DOIUrl":"10.1080/13625187.2026.2692388","url":null,"abstract":"<p><strong>Background: </strong>Paired hormonal data spanning a full androgen panel before and during etonogestrel (ENG) implant use are scarce. We quantified within-subject hormonal change about one year after ENG implant insertion and tested whether it differed by menstrual bleeding phenotype.</p><p><strong>Methods: </strong>In this paired cohort study, 200 women with an ENG 68 mg implant <i>in situ</i> for 10-14 months attended a single index visit. Pre-insertion hormone values, obtained routinely before insertion, were retrieved from records; current values were measured at the index visit in the same laboratory. Paired comparisons used the Wilcoxon signed-rank test, reporting Cohen's dz and absolute change with 95% CIs; post-implant values were compared between bleeding phenotypes by ANCOVA adjusted for age, BMI, and parity, with multiple-testing correction.</p><p><strong>Results: </strong>LH showed the largest decrease (-47.1%; dz = 1.84), followed by SHBG (-49.8%; dz = 1.42), total testosterone (-45.3%; dz = 1.24), and free testosterone (-46.0%; dz = 1.08). Oestradiol, AMH, and DHEA-S changed by ≤3% and, though significant, were clinically negligible (dz ≤ 0.60). Regular monthly bleeding fell from 95.5% to 45.0% (<i>p</i> < 0.001), with no frequent, prolonged, or heavy bleeding. After adjustment, no hormonal value differed by bleeding phenotype (all <i>p</i> ≥ 0.38).</p><p><strong>Conclusion: </strong>One year after ENG implant insertion, deep LH suppression was accompanied by parallel reduction of gonadal androgens (total and free testosterone) and SHBG, whereas oestradiol, AMH, and adrenal DHEA-S were essentially unchanged, indicating a dissociation between suppressed gonadal and preserved adrenal androgens. The reduced-bleeding phenotype was not accompanied by differential hormonal change.</p>","PeriodicalId":520795,"journal":{"name":"The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception","volume":" ","pages":"362-370"},"PeriodicalIF":2.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148321649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A titrated low-dose misoprostol protocol for second-trimester abortion (13-26 weeks) in women with one prior cesarean and preterm premature rupture of membranes: a clinical practice report.","authors":"Maorong Wang, Huan Wei, Hong Li, Qing Zhu","doi":"10.1080/13625187.2026.2683392","DOIUrl":"10.1080/13625187.2026.2683392","url":null,"abstract":"<p><strong>Purpose: </strong>To compare two starting doses (50 µg vs. 100 µg) of a titrated low-dose misoprostol regimen after mifepristone for second-trimester abortion in women with one prior cesarean and premature rupture of membranes (PROM).</p><p><strong>Materials and methods: </strong>We retrospectively analyzed 271 eligible women at 13-26 weeks from 6,636 undergoing second-trimester abortion. All received 200 mg mifepristone, followed at 36 h by titrated misoprostol (initial 50 or 100 µg every 3 h, maximum 4 doses per day, escalated to 400 µg based on uterine response). Induction-to-abortion time, total dose, success rates and complications were compared between gestational age groups (13-16 and 16⁺¹-26 weeks) and initial doses using t-tests, chi-square tests, and multivariable regression.</p><p><strong>Results: </strong>Induction-to-abortion time was similar across groups (15.4-18.6 h). Total misoprostol dose was significantly lower with 50 µg (372-518 µg) than 100 µg (778-878 µg). No uterine rupture or severe hemorrhage occurred. Success rates within 48 h were high (95.7%-97%) and comparable.</p><p><strong>Conclusions: </strong>The 50 µg starting dose significantly reduced total drug exposure, with similarly high success rates and no observed uterine ruptures. These findings suggest a potentially safe, individualized approach, but require confirmation in prospective randomized trials against standard higher-dose regimens.</p>","PeriodicalId":520795,"journal":{"name":"The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception","volume":" ","pages":"383-393"},"PeriodicalIF":2.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148214229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Current approaches to the diagnosis and management of retained products of conception and enhanced myometrial vascularity of the first trimester.","authors":"Umberto Scovazzi, Anjeza Xholli, Elvira Primizia, Ambrogio Pietro Londero, Francesca Cremonini, Isabella Perugi, Filippo Molinari, Angela Costantino, Angelo Cagnacci, Ezio Fulcheri","doi":"10.1080/13625187.2026.2695184","DOIUrl":"10.1080/13625187.2026.2695184","url":null,"abstract":"<p><p><b>Introduction:</b>Aim of this narrative review is to provide an update on diagnosis, management and outcome of RPOC and EMV diagnosed after first trimester pregnancy. Retained products of conception (RPOC) and enhanced myometrial vascularity (EMV) are considered complications following pregnancy and there is scarce agreement upon their management.</p><p><p><b>Methods:</b>A comprehensive, narrative, research was conducted. A literature review of relevant studies published between 2000 and 2025 was carried out using MEDLINE and the Cochrane library using the following terms: 'Arteriovenous Malformations'[Mesh] OR 'Uterine Haemorrhage'[Mesh] OR 'enhanced myometrial vascularity'[tiab] AND 'Abortion, Incomplete'[Mesh] OR 'Abortion, Induced'[Mesh] OR 'Abortion, Spontaneous'[Mesh] OR 'retained product* of conception'[tiab]. Priority was given to randomised controlled trials, systematic reviews and meta-analyses and validating cohort studies.<b>Results:</b>This review was eventually based on the evidence of 208 articles.<b>Discussion:</b>According to current literature data, RPOC and EMV are common findings after first trimester termination of pregnancy or miscarriage. Both entities have excellent outcome, low complications rate and good fertility outcome following resolution after expectant, medical and surgical management. No significant differences appear by choice of management, however expectant approach may be recommended due to worldwide feasibility, low cost and avoidance of operative risks. Conservative management deals with the patient's commitment to be followed for several weeks necessary for the complete resorption of RPOC and/or EMV.</p><p><strong>Short condensation: </strong>With this review we aim to provide up-to-date and evidence based guidance to physicians managing first trimester RPOC and EMV. This two conditions are frequently encountered in routine gynecological care, yet often misdiagnosed and treated inconsistently.</p>","PeriodicalId":520795,"journal":{"name":"The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception","volume":" ","pages":"394-407"},"PeriodicalIF":2.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148407825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}